ZYNE Zynerba Pharmaceuticals Inc

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.

$0.93  +0.02 (1.66%)
As of 09/22/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  08/05/2015
Outstanding shares:  45,753,079
Average volume:  436,751
Market cap:   $39,805,179
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ03R68
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.59
PS ratio:   0.00
Return on equity:   -58.06%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy